{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:46:45Z","timestamp":1782542805682,"version":"3.54.5"},"reference-count":111,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["febs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Molecular Oncology"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    The main infections that cause cancer in the European Union (EU) are\n                    <jats:italic>Helicobacter pylori<\/jats:italic>\n                    (\n                    <jats:italic>H. pylori<\/jats:italic>\n                    ), human papillomavirus (HPV), hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Altogether, in 2022, these infections accounted for ~\u20095% of all cancers in the EU, mainly of the stomach, cervix uteri and liver. The largest burden of infection\u2010caused cancers was found in the south of the EU and near the eastern border. Substantial progress in the efficacy of interventions against these infections has been made since the release of the 4th edition of the European Code Against Cancer in 2015. Cancers due to infections can increasingly be prevented by prophylactic vaccines (HPV and HBV) and\/or prompt diagnosis and treatment that can either cure (HCV and\n                    <jats:italic>H.\u00a0pylori<\/jats:italic>\n                    ) or slow down the infection (HBV and HIV), thus substantially reducing disease risk. Tools to tackle carcinogenic infections are also increasingly accessible and affordable in the EU, but their implementation is slow. Public awareness, political will and cost\u2010effective protocols are necessary to establish large programmes of vaccination or testing and treatment. Progress monitoring, as well as avoiding disinformation and stigma, is crucial to ensure that advances in medical progress are fully leveraged. The recently published 5th edition of the European Code Against Cancer therefore recommends: (1) vaccinate girls and boys against HBV and HPV at the age recommended in your country; (2) take part in testing and treatment for HBV and HCV, HIV and\n                    <jats:italic>H. pylori<\/jats:italic>\n                    , as recommended in your country.\n                  <\/jats:p>","DOI":"10.1002\/1878-0261.70172","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:09:02Z","timestamp":1768561742000},"page":"96-116","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["European Code Against Cancer, 5th edition \u2013 cancer\u2010causing infections and related interventions"],"prefix":"10.1002","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5604-3689","authenticated-orcid":false,"given":"Catharina Johanna","family":"Alberts","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases Public Health Service (GGD)  Amsterdam The Netherlands"},{"name":"Department of Epidemiology and Data Science Amsterdam UMC  The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bloem","sequence":"additional","affiliation":[{"name":"World Health Organization  Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"de Sanjos\u00e9","sequence":"additional","affiliation":[{"name":"ISGlobal  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Grabar","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d'Epid\u00e9miologie et de Sant\u00e9 Publique, Assistance Publique\u2010Hopitaux de Paris, H\u00f4pital St Antoine  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcis","family":"Leja","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine University of Latvia  Riga Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Malfertheiner","sequence":"additional","affiliation":[{"name":"Medical Department II, University Clinic Ludwig Maximilian University  M\u00fcnchen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Mati\u010di\u010d","sequence":"additional","affiliation":[{"name":"Clinic for Infectious Diseases University Medical Centre Ljubljana  Ljubljana Slovenia"},{"name":"Faculty of Medicine University of Ljubljana  Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"M\u00e9graud","sequence":"additional","affiliation":[{"name":"INSERM U1312 BRIC, University of Bordeaux  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Negro","sequence":"additional","affiliation":[{"name":"University Hospitals of Geneva  Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyn","family":"Plummer","sequence":"additional","affiliation":[{"name":"University of Warwick  UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Schim van der Loeff","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Public Health Service (GGD)  Amsterdam The Netherlands"},{"name":"Amsterdam University Medical Centre  The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Balb\u00edn","sequence":"additional","affiliation":[{"name":"Iberoamerican Cochrane Centre Biomedical Research Institute Sant Pau (IIB Sant Pau)  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Salazar","sequence":"additional","affiliation":[{"name":"Iberoamerican Cochrane Centre Biomedical Research Institute Sant Pau (IIB Sant Pau)  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajo","family":"Zeeb","sequence":"additional","affiliation":[{"name":"Leibniz\u2010Institute for Prevention Research and Epidemiology\u2010BIPS  Bremen Germany"},{"name":"Environmental and Lifestyle Epidemiology Branch International Agency for Research on Cancer  Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0033-9026","authenticated-orcid":false,"given":"Ariadna","family":"Feliu","sequence":"additional","affiliation":[{"name":"Environmental and Lifestyle Epidemiology Branch International Agency for Research on Cancer  Lyon France"},{"name":"Department of Primary Care and Public Health, School of Public Health Imperial College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"D'Souza","sequence":"additional","affiliation":[{"name":"Environmental and Lifestyle Epidemiology Branch International Agency for Research on Cancer  Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4816-113X","authenticated-orcid":false,"given":"David","family":"Ritchie","sequence":"additional","affiliation":[{"name":"Environmental and Lifestyle Epidemiology Branch International Agency for Research on Cancer  Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6848-4687","authenticated-orcid":false,"given":"Carolina","family":"Espina","sequence":"additional","affiliation":[{"name":"Environmental and Lifestyle Epidemiology Branch International Agency for Research on Cancer  Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4181-8071","authenticated-orcid":false,"given":"Silvia","family":"Franceschi","sequence":"additional","affiliation":[{"name":"Centro di Riferimento Oncologico di Aviano (CRO) IRCCS  Aviano Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2026.101592"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2015.10.006"},{"key":"e_1_2_10_4_1","unstructured":"International Agency for Research on Cancer.World code against cancer framework.2022[cited 2025 Jun 4]. Available from:https:\/\/cancer\u2010code\u2010world.iarc.who.int\/"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.70068"},{"key":"e_1_2_10_6_1","unstructured":"IARC monographs biological agents. Volume 100 B. A review of human carcinogens;2012."},{"key":"e_1_2_10_7_1","unstructured":"IARC monographs on the evaluation of carcinogenic risks to humans Volume 90.2007."},{"key":"e_1_2_10_8_1","unstructured":"IARC monorgraphs on the evaluation of carcinogenic risks to humans. Volume 59. Hepatitis viruses: International Agency for Research on Cancer Lyon: Springer;1994."},{"key":"e_1_2_10_9_1","unstructured":"Human immunodeficiency viruses and human T\u2010cell lymphotropic viruses: IARC monographs on the evaluation of carcinogenic risks to humans Vol. 67.1996."},{"key":"e_1_2_10_10_1","unstructured":"Schistosomes liver flukes andHelicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans Volume 61. IARC Lyon;1994. p. 218\u201321."},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)30143-7"},{"key":"e_1_2_10_12_1","unstructured":"IARC biological agents IARC monographs on the evaluation of carcinogenic risks to humans volume 100B.2012."},{"key":"e_1_2_10_13_1","doi-asserted-by":"crossref","unstructured":"WeiF GeorgesD ManI BaussanoI CliffordG.Causal attribution of human papillomavirus types to invasive cervical cancer worldwide: a systematic analysis of the global literature. Available at SSRN 4692586;2024.","DOI":"10.2139\/ssrn.4692586"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30716"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pky045"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(23)01320\u2010X"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00825-3"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.001"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00272-2"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214\u2010109X(20)30459\u20109"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00431-8"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30488-7"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2468\u20102667(21)00164\u2010x"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_2_10_25_1","unstructured":"EUROSTAT.Population (national level). Available from:https:\/\/ec.europa.eu\/eurostat\/cache\/metadata\/en\/demo_pop_esms.htm[accessed August 2024]."},{"key":"e_1_2_10_26_1","unstructured":"Plummeret\u00a0alCancers attributable to infection in the European Union. In preparation."},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2023.102435"},{"key":"e_1_2_10_28_1","volume-title":"Human papillomavirus vaccines: WHO position paper (2022 update)","year":"2022"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.07.046"},{"key":"e_1_2_10_30_1","volume-title":"ECDC evidence brief: prevention of hepatitis B and C in the EU\/EEA","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2024"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.86"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djae042"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(21)02178\u20104"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djad263"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917338"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100401"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pky076"},{"key":"e_1_2_10_38_1","first-page":"350","article-title":"Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis","volume":"12","author":"Bogaards JA","year":"2015","journal-title":"BMJ"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102467"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1098-3"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.70197"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/biology12010023"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-320007"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.11.021"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104429"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.10.033"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-024-08512-8"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214\u2010109X(20)30505\u20102"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32314"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.10.008"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885\u2010022\u201009413\u20107"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.03.018"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2022.11.012"},{"issue":"3","key":"e_1_2_10_54_1","article-title":"Long\u2010term benefits from early antiretroviral therapy initiation in HIV infection","volume":"2","author":"Lundgren JD","year":"2023","journal-title":"NEJM Evid"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001798"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2014.08.003"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322200"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5016"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14586"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1909666"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.12.033"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315363"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2021.101735"},{"key":"e_1_2_10_64_1","volume-title":"Population\u2010based Helicobacter pylori screen\u2010and\u2010treat strategies for gastric cancer prevention: guidance on implementation (IARC Working Group Reports No. 12)","author":"Park JY","year":"2025"},{"key":"e_1_2_10_65_1","unstructured":"CaneloC Alonso CoelloP FranceschiS AlbertsC M\u00e9graudF BloemP et\u00a0al.Efficacy and safety of treatment of persistent HCV infection to prevent progression to liver disease. PROSPERO;2024. Available fromhttps:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42023490512."},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i30.4182"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32111-1"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix364"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-19-0162"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.08.030"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24663"},{"key":"e_1_2_10_72_1","unstructured":"SalazarJ RodriguezY CaneloC Alonso CoelloP FranceschiS AlbertsC et\u00a0al.Effectiveness of DDA treatment of persistent HCV infection aged in non\u2010specialist centres to prevent progression to liver disease. PROSPERO;2024. Available fromhttps:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42023490447"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac225"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003653"},{"key":"e_1_2_10_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz546"},{"key":"e_1_2_10_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30120-5"},{"key":"e_1_2_10_77_1","unstructured":"deFiol RoqueM BeltranJ CaneloC Alonso CoelloP FranceschiS AlbertsC et\u00a0al.Effectiveness of screen\u2010 and\u2010treat for helicobacter pylori to prevent progression to gastric disease. PROSPERO; 2024. Available from:https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42023490442"},{"key":"e_1_2_10_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.06.006"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.01.008"},{"key":"e_1_2_10_80_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10071038"},{"key":"e_1_2_10_81_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckz185.375"},{"key":"e_1_2_10_82_1","unstructured":"World Health Organization.HPV dashboard.2024. Available from:https:\/\/www.who.int\/teams\/immunization\u2010vaccines\u2010and\u2010biologicals\/diseases\/human\u2010papillomavirus\u2010vaccines\u2010(HPV)\/hpv\u2010clearing\u2010house\/hpv\u2010dashboard[accessed July 2024]."},{"key":"e_1_2_10_83_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr2030640"},{"key":"e_1_2_10_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198\u2010018\u20100996\u20109"},{"key":"e_1_2_10_85_1","volume-title":"Public health guidance on HIV, hepatitis B and C testing in the EU\/EEA: an integrated approach","year":"2018"},{"key":"e_1_2_10_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13413"},{"key":"e_1_2_10_87_1","volume-title":"Priorities in planning person\u2010centred hepatitis B and C testing services: operational guide","year":"2024"},{"key":"e_1_2_10_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12569"},{"key":"e_1_2_10_89_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134363"},{"key":"e_1_2_10_90_1","unstructured":"Antenatal screening for HIV hepatitis B syphilis and rubella susceptibility in the EU\/EEA \u2013 a member state survey of policies and practices in the prevention of mother\u2010to\u2010child transmission ECDC. European Centre for Disease Prevention and Control;2016."},{"key":"e_1_2_10_91_1","volume-title":"Monitoring of the responses to the hepatitis B and C epidemics in EU\/EEA countries, 2023","author":"European Centre for Disease Prevention and Control","year":"2024"},{"key":"e_1_2_10_92_1","volume-title":"UNAIDS data 2022","author":"UNAIDS","year":"2023"},{"key":"e_1_2_10_93_1","volume-title":"HIV\/AIDS surveillance in Europe 2023\u20132022 Data","author":"European Centre for Disease Prevention and Control\/WHO Regional Office for Europe","year":"2023"},{"key":"e_1_2_10_94_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.12.022"},{"key":"e_1_2_10_95_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327745"},{"key":"e_1_2_10_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100877"},{"key":"e_1_2_10_97_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6902a1"},{"key":"e_1_2_10_98_1","doi-asserted-by":"publisher","DOI":"10.1177\/00333549211054085"},{"key":"e_1_2_10_99_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7201a1"},{"key":"e_1_2_10_100_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13080681"},{"key":"e_1_2_10_101_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102017\u2010016999"},{"key":"e_1_2_10_102_1","unstructured":"Eurohelican.Accelerating gastric cancer reduction in Europe throughHelicobacter pylorieradication (Eurohelican). Available from:https:\/\/nijz.si\/projekti\/eurohelican[accessed 2024]."},{"key":"e_1_2_10_103_1","unstructured":"Towards gastric cancer screening implementation in the European Union (TOGAS). Available from:https:\/\/www.togas.lu.lv\/[accessed July 2024]."},{"key":"e_1_2_10_104_1","first-page":"1","article-title":"Council recommendation of 21 June 2024 on vaccine\u2010preventable cancers","volume":"4259","year":"2024","journal-title":"OJEU"},{"key":"e_1_2_10_105_1","volume-title":"Prevention of hepatitis B and C in the EU\/EEA","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2022"},{"key":"e_1_2_10_106_1","volume-title":"Regional action plans for ending AIDS and the epidemics of viral hepatitis and sexually transmitted infections 2022\u20132030","year":"2023"},{"key":"e_1_2_10_107_1","volume-title":"Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection","year":"2024"},{"key":"e_1_2_10_108_1","unstructured":"European Commission Directorate\u2010General for Health and Food Safety.Council recommendation on strengthening prevention through early detection: a new EU approach on cancer screening replacing\u00a0council recommendation 2003\/878\/ec.2022. Available from:https:\/\/eur\u2010lex.europa.eu\/legal\u2010content\/EN\/TXT\/?uri=celex%3A32022H1213%2801%29"},{"key":"e_1_2_10_109_1","volume-title":"Council recommendation on strengthening prevention through early detection: a new EU approach on cancer screening replacing council recommendation 2003\/878\/EC","year":"2022"},{"key":"e_1_2_10_110_1","unstructured":"Europe's beating cancer plan communication from the commission to the European Parliament and the Council. COM\/2021\/44 final. Available from:https:\/\/ec.europa.eu\/health\/sites\/health\/files\/non_communicable_diseases\/docs\/eu_cancer\u2010plan_en.pdf"},{"key":"e_1_2_10_111_1","volume-title":"Tackling NCDs: best buys and other recommended interventions for the prevention and control of noncommunicable diseases, second edition","year":"2024"},{"key":"e_1_2_10_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20103018(23)00334\u2010X"}],"container-title":["Molecular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1878-0261.70172","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/1878-0261.70172","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1878-0261.70172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:02:39Z","timestamp":1782540159000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1002\/1878-0261.70172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1002\/1878-0261.70172"],"URL":"https:\/\/doi.org\/10.1002\/1878-0261.70172","archive":["Portico"],"relation":{},"ISSN":["1574-7891","1878-0261"],"issn-type":[{"value":"1574-7891","type":"print"},{"value":"1878-0261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-07-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}